SCHEMBL2768196

SCHEMBL2768196

CCC(CC)NC(=O)C1CCN(c2cc(F)c(OC)cc2F)CC1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.51
ACACB O00763 1/20 0.48
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 2/20 0.42
MALT1 Q9UDY8 1/20 0.42
HTR1A P08908 1/20 0.40
HTR1D P28221 1/20 0.40
HTR1B P28222 1/20 0.40
HTR2C P28335 1/20 0.40
CHRM4 P08173 1/20 0.40
GAA P10253 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
CASP3 P42574 1/20 0.38
TAS1R3 Q7RTX0 2/20 0.38
TAS1R1 Q7RTX1 2/20 0.38
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2768295 0.86 KDM4E (0.44) FFAR4ALDH1A1KDM4EGAAMEN1
SCHEMBL2766487 0.80 FFAR4 (0.59) FFAR4ACACBALDH1A1KDM4EMALT1
SCHEMBL2767535 0.80 HPGD (0.56) FFAR4ALDH1A1KDM4EMEN1KMT2A
SCHEMBL2767859 0.75 FFAR4 (0.51) FFAR4ACACBALDH1A1KDM4EGAA
SCHEMBL2766678 0.71 FFAR4 (0.54) FFAR4ACACBALDH1A1GAA
SCHEMBL2769245 0.68 FFAR4 (0.49) FFAR4ACACBALDH1A1KMT2A
SCHEMBL2766664 0.68 FFAR4 (0.50) FFAR4ACACBALDH1A1
SCHEMBL8333126 0.68 GAA (0.45) ACACBALDH1A1KDM4EGAAMEN1
SCHEMBL16482930 0.67 FFAR4 (1.00) FFAR4
SCHEMBL2768381 0.67 SLC6A2 (0.55) FFAR4ALDH1A1HTR1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627871-B1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE ASKA PHARM CO LTD (JP) 2010-04-14 EP disclosed
US-7449466-B2 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2008-11-11 US disclosed
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2006-08-24 US disclosed
EP-1627871-A1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE Teikoku Hormone Mfg. Co., Ltd. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative SHBG, STS, ARSA FFAR4 2828/4885ACACB 350/4885ALDH1A1 2953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.